SCHEMBL30863474

SCHEMBL30863474

COc1ccc(NC(=O)c2ccc(OCCN(C)C)cc2)c2ccncc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 3/20 0.51
▸ BCR P11274 3/20 0.51
▸ DRD2 P14416 2/20 0.49
▸ DRD3 P35462 2/20 0.49
▸ HRH3 Q9Y5N1 1/20 0.49
▸ CACNA1H O95180 3/20 0.47
▸ CACNA1B Q00975 2/20 0.47
▸ MCHR1 Q99705 1/20 0.46
▸ MAPK1 P28482 2/20 0.45
▸ TSHR P16473 2/20 0.45
▸ MAPT P10636 2/20 0.45
▸ LMNA P02545 2/20 0.45
▸ ACHE P22303 1/20 0.45
▸ SLC6A2 P23975 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ KCNH2 Q12809 1/20 0.45
▸ CHRNB2 P17787 1/20 0.44
▸ CHRNB4 P30926 1/20 0.44
▸ CHRNA3 P32297 1/20 0.44
▸ CHRNA4 P43681 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27195981 1.00 ABL1 (0.51) ABL1BCRDRD2DRD3HRH3
SCHEMBL30863471 0.87 CACNA1H (0.48) ABL1BCRHRH3CACNA1HCACNA1B
SCHEMBL27195732 0.87 CACNA1H (0.48) ABL1BCRHRH3CACNA1HCACNA1B
SCHEMBL27195800 0.85 CACNA1H (0.48) ABL1BCRHRH3CACNA1HCACNA1B
SCHEMBL30806978 0.83 BRPF1 (0.49) MCHR1TSHRMAPTLMNASMN1; SMN2
SCHEMBL27195733 0.82 TRPV1 (0.59) CACNA1HCACNA1BMAPK1MAPTLMNA
SCHEMBL27195708 0.82 CACNA1H (0.51) ABL1BCRHRH3CACNA1HCACNA1B
Hydrochloric Acid SCHEMBL30863454 0.82 CACNA1H (0.43) ABL1BCRHRH3CACNA1HCACNA1B
SCHEMBL30863554 0.81 KMT2A (0.49) ABL1BCRDRD2DRD3HRH3
SCHEMBL30863430 0.81 KMT2A (0.49) ABL1BCRDRD2DRD3HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581017-A1 NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS Biodol Therapeutics (FR) 2025-07-09 — — EP disclosed
WO-2024079072-A1 NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS BIODOL THERAPEUTICS (FR) 2024-04-18 — — WO disclosed
Send feedback